INS and early-onset autosomal dominant Alzheimer disease: Additionally, intranasal insulin administration improves memory function, augments synaptic proteins, and significantly reduces microglia-mediated inflammation in the hippocampus in Alzheimer’s disease or traumatic brain injury in animals (Chen et al., 2014; Brabazon et al., 2017).